FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 55 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,061 | -49.4% | 4,136 | -40.5% | 0.00% | – |
| Q2 2023 | $61,369 | +2310.4% | 6,950 | +2171.2% | 0.00% | – |
| Q1 2023 | $2,546 | -80.4% | 306 | -78.1% | 0.00% | – |
| Q3 2021 | $13,000 | +30.0% | 1,400 | 0.0% | 0.00% | – |
| Q2 2021 | $10,000 | -99.1% | 1,400 | -99.2% | 0.00% | – |
| Q1 2021 | $1,155,000 | +182.4% | 185,909 | +238.2% | 0.00% | – |
| Q4 2020 | $409,000 | +32.8% | 54,968 | +8.1% | 0.00% | – |
| Q3 2020 | $308,000 | +190.6% | 50,846 | +298.8% | 0.00% | – |
| Q2 2020 | $106,000 | +863.6% | 12,749 | +608.3% | 0.00% | – |
| Q1 2020 | $11,000 | +175.0% | 1,800 | +67.6% | 0.00% | – |
| Q2 2019 | $4,000 | -94.7% | 1,074 | -93.0% | 0.00% | – |
| Q1 2019 | $75,000 | -23.5% | 15,408 | -0.1% | 0.00% | – |
| Q4 2018 | $98,000 | +600.0% | 15,425 | +764.6% | 0.00% | – |
| Q3 2018 | $14,000 | 0.0% | 1,784 | +28.5% | 0.00% | – |
| Q2 2018 | $14,000 | – | 1,388 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
| Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
| DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
| AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
| Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
| Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
| 683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |